Stay updated on Extension of AK002 in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA consolidated 'Locations' section has been added listing study sites across Arizona, California, Florida, Illinois, Iowa, Maryland, Massachusetts, Minnesota, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, and Utah, and the revision tag shows v3.3.3.SummaryDifference2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe page shows a new site revision (v3.3.2) added and the previous revision (v3.2.0) removed, which seems to be a maintenance update rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved administrative funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedThe page updates seem limited to layout and styling with no changes to the study's core details (conditions, AK002 dosing plan, outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check86 days agoChange DetectedUpgrade notice added with funding-related status and a version bump to v3.2.0; removal of the old v3.1.0 reference.SummaryDifference4%

- Check100 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Extension of AK002 in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page.